drug · small molecule
BIMATOPROST
Phase 2updated 5mo agoby $AMRX Amneal Pharmaceuticals, Inc.🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 5Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 8 investigational indications.
targets
Prostaglandin F2-alpha receptor
all catalysts(0)
nothing on the calendar yet
Trials studying BIMATOPROST
- phase3A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
- phase2A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)
- phase3Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
- phase4Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
- phase3Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
- phase3Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
- N/AEvaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle Glaucoma
- phase2Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that